Home » Topics » Disease categories and therapies » Nephrology

Nephrology
RSS

Lilly Icos continues to develop PDE5 inhibitors

June 27, 2002

Recent patent covers new PDE5 inhibitors designed at Lilly Icos

June 21, 2002

Trospium completes phase III trial in overactive bladder

June 20, 2002

Senju patents novel Na+/Ca2+ exchange inhibitors

June 19, 2002

Boehringer Ingelheim claims new agents for urinary incontinence

June 18, 2002

Shire files for approval of Fosrenol in Canada

June 11, 2002

Nasal apomorphine set to enter phase I trials for erectile dysfunction

June 7, 2002

IPD-1151T may be preferable to other drugs in the treatment of interstitial cystitis

June 6, 2002

A possible role for the nicotinic agonist epibatidine in neurogenic voiding dysfunction

June 6, 2002

KW-7158 depresses bladder hyperactivity through afferent pathways

June 6, 2002

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...